ChemicalBook > CAS DataBase List > Capmatinib hydrochloride

Capmatinib hydrochloride

Product Name
Capmatinib hydrochloride
CAS No.
1865733-40-9
Chemical Name
Capmatinib hydrochloride
Synonyms
INC-280 2HCl.H2O;INCB28060 2HCl.H2O;NVP-INC280 2HCl.H2O;Capmatinib 2HCl.H2O;Capmatinib HCl hydrate;Capmatinib hydrochloride;Capmatinib hydrochloride Hydrate;Capmatinib HCl hydrate (INCB-28060;Capmatinib dihydrochloride hydrate;Capmatinib Hydrochloride Hydrate (INCB28060)
CBNumber
CB04848242
Molecular Formula
C23H20ClFN6O2
Formula Weight
466.9
MOL File
1865733-40-9.mol
More
Less

Capmatinib hydrochloride Property

form 
Solid
color 
White to light yellow
InChIKey
XCHIKTXPDQTRMI-UHFFFAOYSA-N
SMILES
C(C1C=CC2N=CC=CC=2C=1)C1=CN=C2N=CC(C3C=CC(C(=O)NC)=C(F)C=3)=NN12.Cl.O
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Capmatinib hydrochloride Chemical Properties,Usage,Production

Description

Capmatinib dihydrochloride hydrate is a orally active,reversible MET tyrosine kinase inhibitor that received approval for advanced non-small cell lung cancer(NSCLC) harboring MET exon 14 skipping mutationa. Capmatinib dihydrochloride hydrate can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib dihydrochloride hydrate potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. Capmatinib dihydrochloride hydrate is largely metabolized by CYP3A4 and aldehyde oxidase[1-3].

Origin

Capmatinib was first reported in 2011 by Liu et al., who showed that in both in vivo and in vitro mice studies using human cell lines, capmatinib had a 10,000-fold selectivity for c-met over a large panel of human kinase. They showed that capmatinib can block the c-MET phosphorylation and activation of downstream targets, including HGF. They further showed that activated c-met upregulates cancer-promoting EGFR and HER-3 pathways. Baltschukat et al. further investigated capmatinib in NSCLC[4].

Mechanism of action

Tabrecta (capmatinib) is a kinase inhibitor that targets MET, including the mutant variant produced by exon 14 skipping. MET exon 14 skipping results in a protein with a missing regulatory domain that reduces its negative regulation, leading to increased downstream MET signaling.

Toxicity evaluation

Effects During Pregnancy and Lactation No information is available on the clinical use of capmatinib during breastfeeding. Because capmatinib is 96% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during capmatinib therapy and for 1 week after the last dose.

References

[1] HSUROBERT NagasakaMisako BenjaminDavid J. The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review.[J]. Cancers, 2023. DOI:10.3390/cancers15143561.
[2] LIUXIANGDONG. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3.[J]. Clinical Cancer Research, 2011. DOI:10.1158/1078-0432.CCR-11-1157.
[3] BALTSCHUKATSABRINA. Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.[J]. Clinical Cancer Research, 2019. DOI:10.1158/1078-0432.CCR-18-2814.
[4] HsuRobert, NagasakaMisako, BenjaminDavid J. "The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review." Cancers 15 14 (2023).

Capmatinib hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Capmatinib hydrochloride Suppliers

Suzhou Ryan Pharmaceutical Technology Co., Ltd.
Tel
0512-68780025 18962125825
Email
sales@ryanchem.com
Country
China
ProdList
163
Advantage
62
Shanghai Hope Chem Co., Ltd.,
Tel
+21-18501659228 18501659228
Fax
sales@hope-chem.com
Email
info@hope-chem.com
Country
China
ProdList
479
Advantage
55
Jinan XinKe Pharmaceutical Technology Co., Ltd.
Tel
0531-88259693 17854196142
Fax
0531-88259693
Email
2820602043@qq.com
Country
China
ProdList
83
Advantage
58
Suzhou Albertchem Co.,Ltd.
Tel
0512-88968486 18012631750
Email
sales@albertchemical.com
Country
China
ProdList
285
Advantage
58
Tianjin Zhongcheng Mingyuan Technology Co., Ltd.
Tel
13302022156
Fax
-
Email
3506745780@qq.com
Country
China
ProdList
174
Advantage
58
Cangzhou Enke Pharma-tech Co., Ltd.
Tel
0317-5296180 15533709196
Fax
0317-5106596
Email
sale@enkepharma.com
Country
China
ProdList
1896
Advantage
55
Beijing Mesochem Technology Co., Ltd.
Tel
010-57862036 18811083386
Email
msales@mesochem.com
Country
China
ProdList
205
Advantage
58
Shanghai Yu Ben Biotechnology Co., Ltd.
Tel
15502154572
Fax
-
Email
yuben012@sina.com
Country
China
ProdList
503
Advantage
58
DC Chemicals
Tel
021-58447131 13564518121
Email
sales@dcchemicals.com
Country
China
ProdList
9409
Advantage
58
Wuhan Dingxintong Pharmaceutical Co. , Ltd.
Tel
027-52344656 15871722230
Fax
2796190295
Email
15871722230@163.com
Country
China
ProdList
4899
Advantage
58
Shanghai Prescrina Pharmaceutical Technology Co., LTD
Tel
18367323072
Email
2125193158@qq.com
Country
China
ProdList
367
Advantage
58
Wuhan Augda Biotechnology Co., Ltd
Tel
15071299552
Fax
QQ:262933239
Email
262933239@qq.com
Country
China
ProdList
6887
Advantage
58
Kaifeng Mingren Pharmaceutical Co.,LTD
Tel
0371-65741762
Fax
QQ:2860768577
Email
sales@hasunny.com
Country
China
ProdList
2380
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6753
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
400-880-2824 15608648206
Email
1987516016@qq.com
Country
China
ProdList
2815
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24644
Advantage
58
Pushan Industry (Shaanxi) Co., Ltd.
Tel
029-81310890 13571859809
Email
info@pushanshiye.com
Country
China
ProdList
10000
Advantage
58
ShenZhen Trendseen Biological Technology Co.,Ltd.
Tel
13417589054 13417589054
Email
trendseenbio@gmail.com
Country
China
ProdList
9470
Advantage
58
Shaanxi Didu New Material Co., Ltd
Tel
029-81145920 15353716720
Email
1046@dideu.com
Country
China
ProdList
9975
Advantage
58
Taizhou Creating Bio-pharm Co.,Ltd.
Tel
+86-0576-88827176 +86-18906581668
Email
post@creatingchemical.com
Country
China
ProdList
229
Advantage
58
Nanjing Lebang Pharmaceutical Technology Co., Ltd
Tel
18860950986
Email
tangmanman@lebangpharma.com
Country
China
ProdList
560
Advantage
58
Nantong Zhonghe Chemical New Materials Co., Ltd
Tel
13003551299 13003551299
Email
2369399482@qq.com
Country
China
ProdList
7566
Advantage
58
Anqing YanZhi Pharma Discovery Co.,Ltd.
Tel
18055651951
Email
2272561977@qq.com
Country
China
ProdList
421
Advantage
58
Shanghai Youna Biopharmaceutical Co., Ltd
Tel
18164002430
Email
511710754@qq.com
Country
China
ProdList
228
Advantage
58
Suzhou Haijing Pharmaceutical Technology Co., Ltd
Tel
18662190408 18662190408
Email
275443226@qq.com
Country
China
ProdList
53
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12005
Advantage
58
Hubei Kailong Biotechnology Co.,Ltd.
Tel
19526384105
Email
3671394075@qq.com
Country
China
ProdList
2864
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9266
Advantage
58
Wuhan Circle Star Chem-medic Technology Co.,Ltd
Tel
18908653704
Email
marketing@circlestar-chem.com
Country
China
ProdList
5001
Advantage
58
Jinan Million Pharmaceutical Co., Ltd
Tel
0531-68659554 13031714605
Email
3299907431@qq.com
Country
China
ProdList
115
Advantage
58
Minglong (Xianning) Pharmaceutical Co., LTD
Tel
155-7155-6913 15571556913
Email
354024111@qq.com
Country
China
ProdList
2614
Advantage
58
Cangzhou Enke Pharma Tech Co.,ltd.
Tel
0317-5106596 15533709196
Email
1154424302@qq.com
Country
China
ProdList
1891
Advantage
58
Wuhan Circle Star Chem-medical Technology Co.,Ltd
Tel
+undefined13437180835
Email
Janel@circlestar-chem.com
Country
China
ProdList
1000
Advantage
58
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Tel
+86-18600796368 +86-18600796368
Email
sales@sjar-tech.com
Country
China
ProdList
456
Advantage
58
Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd.
Tel
+86-0311-67591193 +8613931880626
Fax
86-311-67591193
Email
sales02@dingminpharma.com
Country
China
ProdList
252
Advantage
58
Fuzhou Lista Biotechnology Co.,Ltd
Tel
Email
sallychris2021@gmail.com
Country
China
ProdList
75
Advantage
58
SUZHOU SENFEIDA CHEMICAL CO.,LTD
Tel
+86-0512-83500002 +8615195660023
Email
sales@senfeida.com
Country
China
ProdList
23046
Advantage
58
Taizhou Creating Bio-pharm co., ltd.
Tel
+8613586099526
Email
post@creatingbiopharm.com
Country
China
ProdList
217
Advantage
58
Wuhan Jingkang en Biomedical Technology Co., Ltd
Tel
+8613720134139
Email
orders@jknbiochem.com
Country
China
ProdList
5221
Advantage
58
Jinan Million Pharmaceutical Co., Ltd
Tel
0531-68659554 +8613031714605
Fax
Room1-2208, Gaoxin district, Jinan, Shandong
Email
info@millionpharm.com
Country
China
ProdList
252
Advantage
58
Zison Pharmaceutical (Shandong) Co., Ltd.
Tel
+86-0086-531-88259693 +86-18660188356
Email
tracy.li@zisonpharm.com
Country
China
ProdList
57
Advantage
58
Wuhan Topule Biopharmaceutical Co., Ltd
Tel
+8618327326525
Email
masar@topule.com
Country
China
ProdList
8467
Advantage
58
Beijing Mesochem Technology Co.,Ltd
Tel
+8613651027935
Fax
+86-10-57862181
Email
rachel@mesochem.com
Country
China
ProdList
191
Advantage
58
More
Less

View Lastest Price from Capmatinib hydrochloride manufacturers

Zison Pharmaceutical (Shandong) Co., Ltd.
Product
Capmatinib hydrochloride Hydrate 1865733-40-9
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
>99% by HPLC
Supply Ability
10kg/month
Release date
2023-07-22
Jinan Million Pharmaceutical Co., Ltd
Product
Capmatinib hydrochloride 1865733-40-9
Price
US $1.00-0.50/kg
Min. Order
1kg
Purity
99%
Supply Ability
200kg
Release date
2023-12-11
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Product
Capmatinib Hydrochloride 1865733-40-9
Price
US $0.00/g
Min. Order
1g
Purity
More Than 99%
Supply Ability
100kg/Month
Release date
2024-11-04

1865733-40-9, Capmatinib hydrochlorideRelated Search:


  • Capmatinib hydrochloride
  • Capmatinib hydrochloride Hydrate
  • Capmatinib HCl hydrate (INCB-28060
  • Capmatinib 2HCl.H2O
  • INC-280 2HCl.H2O
  • INCB28060 2HCl.H2O
  • NVP-INC280 2HCl.H2O
  • Capmatinib Hydrochloride Hydrate (INCB28060)
  • S114,SNU-5,ATP competitive,Balb/c nu/nu mice,U-87MG,INCB-28060 dihydrochloride,orally active,Capmatinib dihydrochloride,Capmatinib 2HCl.H-2O,Capmatinib 2HCl.H2O,INC280 dihydrochloride,Apoptosis,inhibit,Inhibitor,c-Met/HGFR,H441
  • 2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide dihydrochloride monohydrate
  • Capmatinib dihydrochloride hydrate
  • Capmatinib HCl hydrate
  • 1865733-40-9
  • C23H17FN6O2HClH2O